Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estazolam for postoperative pain and knee function in anxious TKA patients
ChiCTR2500099545Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estazolam in knee osteoarthritis (OA) and anxiety disorder (3 arms), sponsored by Xi'an Honghui Hospital. Primary endpoints: Pain (VAS score), Knee function (WOMAC and KSS) and 1 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
estazolam
03
Conditions
knee osteoarthritis (OA)anxiety disorder
Beyond the preview
Go deeper on ChiCTR2500099545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099545.